References
Milsom I, Altman D, Cartwright R, et al. Epidemiology of urinary incontinence (UI) and other lower urinary tract symptoms (LUTS), pelvic organ prolapse (POP) and anal (AI) incontinence. In: Incontinence. Cardozo L, Rovner E, Wagg A, Wein A, Abrams P. (Editors). International Consultation on Incontinence. 7th 2023.
Espuña-Pons M, Ros C, Ortega JA, Aliaga F, Pérez-González A, Palau MJ; Pelvic Floor Research Group (Grup de Recerca del Sòl Pelvià, GRESP). Prevalence, incidence, and remission rates of urinary incontinence in women attended in gynecological practice. Neurourol Urodyn. 2017;36(4):1081-1085.
Cardoso Barbosa H, de Queiroz Oliveira JA, Moreira da Costa J, et al. Empowerment-oriented strategies to identify behavior change in patients with chronic diseases: an integrative review of the literature. Patient Educ Couns. 2021;104(4):689-702.
Todhunter-Brown A, Hazelton C, Campbell P, Elders A, Hagen S, McClurg D. Conservative interventions for treating urinary incontinence in women: an Overview of Cochrane systematic reviews. Cochrane Database Syst Rev. 2022;9(9):CD012337.
Soundararajan K, Dilruksha Chandrasiri M, Balchandra P. Staff awareness of pelvic floor muscle training (PFMT) in tertiary care – a qualitative cross-sectional study. J Obstet Gynaecol. 2022;42(6):2282-2286.
Food and Drug Administration. Urogynecologic Surgical Mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. 2011. Available at: https://www.fda.gov/files/medical%20devices/published/Urogynecologic-Surgical-Mesh–Update-on-the-Safety-and-Effectiveness-of-Transvaginal-Placement-for-Pelvic-Organ-Prolapse-%28July-2011%29.pdf
Moore K, Athanasiou S, Chen Z, Gomelsky A, et al. Surgery for urinary incontinence in women. In: Incontinence. Cardozo L, Rovner E, Wagg A, Wein A, Abrams P. (Editors). International Consultation on Incontinence. 7th 2023.
Novakov Mikić A, Lepeš Bingold B, Hreljac I, Vižintin Z. Non-ablative vaginal erbium laser treatment of patients with cystocele and stress urinary incontinence – a retrospective study. Eur Gynecol Obstet. 2023;5(1):4-9.
US Food and Drug Administration. FDA warns against use of energy-based devices to perform vaginal ’rejuvenation’ or vaginal cosmetic procedures: FDA safety communication. Available at:: https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claims
Zhang C, Chen Y, Liu S, Chen J, Shen H, Luo D. Effect of vaginal energy-based treatment on female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials. World J Urol. 2023;41(2):405-411.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Sònia Anglès-Acedo

